Human serum albumin enhances DNA transfection by lipoplexes and confers resistance to inhibition by serum

被引:126
作者
Simoes, S
Slepushkin, V
Pires, P
Gaspar, R
de Lima, MCP
Düzgünes, N
机构
[1] Univ Pacific, Sch Dent, Dept Microbiol, San Francisco, CA 94115 USA
[2] Univ Coimbra, Fac Pharm, Lab Pharmaceut Technol, P-3000 Coimbra, Portugal
[3] Univ Coimbra, Dept Biochem, P-3000 Coimbra, Portugal
[4] Univ Coimbra, Ctr Neurosci, P-3000 Coimbra, Portugal
来源
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES | 2000年 / 1463卷 / 02期
关键词
gene therapy; cationic liposome; human serum albumin; macrophage; in vivo; gene delivery;
D O I
10.1016/S0005-2736(99)00238-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cationic liposome-DNA complexes ('lipoplexes') are used as gene delivery vehicles and may overcome some of the limitations of viral vectors for gene therapy applications. The interaction of highly positively charged lipoplexes with biological macromolecules in blood and tissues is one of the drawbacks of this system. We examined whether coating cationic liposomes with human serum albumin (HSA) could generate complexes that maintained transfection activity. The association of HSA with liposomes composed of 1,2-dioleoyl-3-(trimethylammonium) propane and dioleoylphosphatidylethanolamine, and subsequent complexation with the plasmid pCMVluc greatly increased luciferase expression in epithelial and lymphocytic cell lines above that obtained with plain lipoplexes. The percentage of cells transfected also increased by an order of magnitude. The zeta potential of the ternary complexes was lower than that of the lipoplexes. Transfection activity by HSA-lipoplexes was not inhibited by up to 30% serum. The combined use of HSA and a pH-sensitive peptide resulted in significant gene expression in human primary macrophages. HSA-lipoplexes mediated significantly higher gene expression than plain lipoplexes or naked DNA in the lungs and spleen of mice. Our results indicate that negatively charged HSA-lipoplexes can facilitate efficient transfection of cultured cells, and that they may overcome some of the problems associated with the use of highly positively charged complexes for gene delivery in vivo. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:459 / 469
页数:11
相关论文
共 51 条
[21]   Factors influencing the efficiency of cationic liposome-mediated intravenous gene delivery [J].
Liu, Y ;
Mounkes, LC ;
Liggitt, HD ;
Brown, CS ;
Solodin, I ;
Heath, TD ;
Debs, RJ .
NATURE BIOTECHNOLOGY, 1997, 15 (02) :167-173
[22]   ORIGIN OF THE HIV-SUSCEPTIBLE HUMAN CD4 + CELL-LINE H9 [J].
MANN, DL ;
OBRIEN, SJ ;
GILBERT, DA ;
REID, Y ;
POPOVIC, M ;
READCONNOLE, E ;
GALLO, RC ;
GAZDAR, AF .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1989, 5 (03) :253-255
[23]   (Glyco)-protein drug carriers with an intrinsic therapeutic activity: The concept of dual targeting [J].
Meijer, DKF ;
Molema, G ;
Moolenaar, F ;
deZeeuw, D ;
Swart, PJ .
JOURNAL OF CONTROLLED RELEASE, 1996, 39 (2-3) :163-172
[24]   SITE-SPECIFIC GENE-EXPRESSION INVIVO BY DIRECT GENE-TRANSFER INTO THE ARTERIAL-WALL [J].
NABEL, EG ;
PLAUTZ, G ;
NABEL, GJ .
SCIENCE, 1990, 249 (4974) :1285-1288
[25]   EFFICIENT TRANSFER AND SUSTAINED HIGH EXPRESSION OF THE HUMAN GLUCOCEREBROSIDASE GENE IN MICE AND THEIR FUNCTIONAL MACROPHAGES FOLLOWING TRANSPLANTATION OF BONE-MARROW TRANSDUCED BY A RETROVIRAL VECTOR [J].
OHASHI, T ;
BOGGS, S ;
ROBBINS, P ;
BAHNSON, A ;
PATRENE, K ;
WEI, FS ;
WEI, JF ;
LI, J ;
LUCHT, L ;
FEI, Y ;
CLARK, S ;
KIMAK, M ;
HE, HL ;
MOWERYRUSHTON, P ;
BARRANGER, JA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (23) :11332-11336
[26]  
PACCAUD JP, 1992, J BIOL CHEM, V267, P13102
[27]  
PARENTE RA, 1988, J BIOL CHEM, V263, P4724
[28]  
Pless DD, 1996, J CELL BIOCHEM, V62, P27, DOI 10.1002/(SICI)1097-4644(199607)62:1<27::AID-JCB4>3.0.CO
[29]  
2-3
[30]   Inhibition of human immunodeficiency virus type-1 replication in macrophages and H9 cells by free or liposome-encapsulated L-689,502, an inhibitor of the viral protease [J].
Pretzer, E ;
Flasher, D ;
Duzgunes, N .
ANTIVIRAL RESEARCH, 1997, 34 (01) :1-15